↓ Skip to main content

Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup: a pooled analysis

Overview of attention for article published in The Lancet Respiratory Medicine, June 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

blogs
1 blog
twitter
10 X users
patent
1 patent

Citations

dimensions_citation
131 Dimensions

Readers on

mendeley
208 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup: a pooled analysis
Published in
The Lancet Respiratory Medicine, June 2016
DOI 10.1016/s2213-2600(16)30121-7
Pubmed ID
Authors

J Stuart Elborn, Bonnie W Ramsey, Michael P Boyle, Michael W Konstan, Xiaohong Huang, Gautham Marigowda, David Waltz, Claire E Wainwright, VX-809 TRAFFIC and TRANSPORT study groups

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 208 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
United States 1 <1%
Canada 1 <1%
Unknown 205 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 33 16%
Student > Master 28 13%
Researcher 22 11%
Student > Ph. D. Student 20 10%
Other 15 7%
Other 28 13%
Unknown 62 30%
Readers by discipline Count As %
Medicine and Dentistry 63 30%
Biochemistry, Genetics and Molecular Biology 18 9%
Nursing and Health Professions 13 6%
Agricultural and Biological Sciences 10 5%
Pharmacology, Toxicology and Pharmaceutical Science 10 5%
Other 20 10%
Unknown 74 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2024.
All research outputs
#2,241,070
of 25,944,331 outputs
Outputs from The Lancet Respiratory Medicine
#1,186
of 2,914 outputs
Outputs of similar age
#38,731
of 361,924 outputs
Outputs of similar age from The Lancet Respiratory Medicine
#17
of 77 outputs
Altmetric has tracked 25,944,331 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,914 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 78.8. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,924 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.